Laboratory Corporation of America Holdings has seen several mixed financial trends. Labcorp's quarterly results
surpassed estimates, fuelled by rising demand for diagnostic tests. However, Labcorp's Q3 and Full Year 2023 EPS
missed expectation. The firm announced its
winning bid for select assets of
Invitae, and plans to enhance mpox testing capacity. Furthermore,
Labcorp announced its acquisition of select assets of BioReference Health's Diagnostic Business. Recently, the firm finalised the purchase of select assets of Invitae and
acquired Outreach Laboratory Business. Moreover, Labcorp announced a
partnership with several entities such as Hawthorne Effect, Tufts Medicine, Legacy Health, and Baystate Health. Conversely, it has seen
sell-offs by M&G Plc, QRG Capital Management Inc., Leeward Investments LLC MA, and others. Meanwhile, Labcorp had its status
upgraded to buy at HSBC Global Research after trading 7.6% higher following strong
earnings. It also announced a new deal to boost the clinical diagnostics area.
Laboratory Corporation of America Holdings LH News Analytics from Mon, 13 Jan 2014 08:00:00 GMT to Sat, 09 Nov 2024 11:32:36 GMT -
Rating 5
- Innovation 3
- Information 2
- Rumor -2